Emapgliflozin Audit ADA San Francisco June 2019a - Poster

Characteristics and treatment outcomes of patients treated with empagliflozin in the Association of British Clinical Diabetologists (ABCD) Nationwide Empagliflozin Audit

Ken Y Thong1, Jonathan Chung-Wah-Cheong1, Mahender Yadagiri2, Melissa L Cull2, Alex Bickerton3, Suzanne M Phillips4, Alison Evans4, Devesh K Sennik5, Anurita Rohilla5, Hazel Reid6, Davis S Morris7, Marc Atkin8, Anthony M Robinsonl8, David M Williams8, Jeffrey W Stephens9, Karen Adamson6, Ian W Gallen10, Robert E Ryder2

1Perth, Australia

2Birmingham, United Kingdom

3Yeovil, United Kingdom

4Gloucester, United Kingdom

5Essex, United Kingdom

6Livingston, United Kingdom

7Shrewsbury, United Kingdom

8Bath, United Kingdom

9Swansea, United Kingdom

10Reading, United Kingdom

Discipline: 
Diabetes
Clinical taxonomy: 
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 
Audit
Posters

Information for HCPs

COVID-19 Information for Healthcare Professionals